Vincenzo De Falco - Concepedia

Author

Vincenzo De Falco

University of Campania "Luigi Vanvitelli"ORCID

Also Known As

Falco, Vincenzo De, V. De Falco, Vincenzo De Falco, Vincenzo De Falco, Vincenzo de Falco

Publications

827

Citations

H-Index

Concepts

All Affiliations

University of Campania "Luigi Vanvitelli"The University of Texas MD Anderson Cancer Center Casa Sollievo della Sofferenza European Institute of Oncology University of Turin

About

Vincenzo De Falco is an author at University of Campania "Luigi Vanvitelli" specializing in cancer research, molecular oncology, and colorectal cancer.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Health Sciences	2	2	101
2	Medicine	2	2	101
3	Pathology	2	2	101
4	Surgical Oncology	1	1	65
5	Cancer Epidemiology	1	1	65

Vincenzo De Falco

Publications

483

Citations

H-Index

Page 1

	Year	Citations
Clinical Practice Use of Liquid Biopsy to Identify RAS/BRAF Mutations in Patients with Metastatic Colorectal Cancer (mCRC): A Single Institution Experience Pietro Paolo Vitiello, Vincenzo De Falco, Emilio Francesco Giunta, Cancers Surgical OncologyCancer PathologyPathologyTumor BiologyGastrointestinal Oncology	2019	65
Panitumumab Plus Trifluridine-Tipiracil as Anti–Epidermal Growth Factor Receptor Rechallenge Therapy for Refractory <i>RAS</i> Wild-Type Metastatic Colorectal Cancer Stefania Napolitano, Vincenzo De Falco, Giulia Martini, JAMA Oncology	2023	53
Triple blockade of EGFR, MEK and PD-L1 has antitumor activity in colorectal cancer models with constitutive activation of MAPK signaling and PD-L1 overexpression Stefania Napolitano, Nunzia Matrone, A. L. Muddassir, Journal of Experimental & Clinical Cancer Research	2019	38
Vulnerability to low-dose combination of irinotecan and niraparib in ATM-mutated colorectal cancer Pietro Paolo Vitiello, Giulia Martini, Luigi Mele, Journal of Experimental & Clinical Cancer Research	2021	37
Panitumumab plus trifluridine/tipiracil as anti‐<scp>EGFR</scp> rechallenge therapy in patients with refractory <scp><i>RAS</i></scp> wild‐type metastatic colorectal cancer: Overall survival and subgroup analysis of the randomized phase <scp>II VELO</scp> trial Stefania Napolitano, Davide Ciardiello, Vincenzo De Falco, International Journal of Cancer OncologyOverall SurvivalGastrointestinal OncologyClinical TrialsColorectal Cancer	2023	36
Combined blockade of MEK and PI3KCA as an effective antitumor strategy in HER2 gene amplified human colorectal cancer models Valentina Belli, Nunzia Matrone, Stefania Napolitano, Journal of Experimental & Clinical Cancer Research	2019	34
Baseline IFN-γ and IL-10 expression in PBMCs could predict response to PD-1 checkpoint inhibitors in advanced melanoma patients Emilio Francesco Giunta, Giusi Barra, Vincenzo De Falco, Scientific Reports	2020	34
Mitochondrial transfer from Adipose stem cells to breast cancer cells drives multi-drug resistance Vitale Del Vecchio, Ayesha Rehman, Sameer Kumar Panda, Journal of Experimental & Clinical Cancer Research	2024	34
Comprehensive genome profiling by next generation sequencing of circulating tumor DNA in solid tumors: a single academic institution experience Vincenza Caputo, Vincenzo De Falco, Anna Ventriglia, Therapeutic Advances in Medical Oncology	2022	29
Feasibility of next-generation sequencing in clinical practice: results of a pilot study in the Department of Precision Medicine at the University of Campania ‘Luigi Vanvitelli’ Vincenzo De Falco, L. Poliero, Pietro Paolo Vitiello, ESMO Open	2020	22

Page 1